Laval, McGill researchers receive $3.6M in private funding for medical research
June 8, 2020
Université Laval and McGill University researchers have received $3.6M in funding to support medical research. AmorChem will provide $1.2M to a Laval researcher Serge Rivest to investigate a treatment for Alzheimer’s disease, while two researchers at McGill will receive $1.2M each to explore treatments for ovarian cancer and the development of anti-inflammatory drugs. ArmorChem has stated that these investments are meant to help researchers continue these projects even as COVID-19 causes delays. Journal de Montréal (QC)
